Loading...

Lannett Company, Inc.

LCINYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$0.69
$0.03(3.86%)

Lannett Company, Inc. (LCI) Stock Overview

Explore Lannett Company, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.1/100

Key Financials

Market Cap7.4M
P/E Ratio-0.03
EPS (TTM)$-19.14
ROE1.66%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.01

LCI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lannett Company, Inc. (LCI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 7.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;